v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (3,149) $ (3,595)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,599 331
Stock-based compensation 5,634 1,720
Change in fair value of warrants (15,946) 2,728
Changes in operating assets and liabilities    
(Increase)/ decrease in trade receivables, net (4,624) 2,605
Increase in prepaid expenses and other operating assets (747) (623)
Increase/ (decrease) in trade payables (321) 238
Decrease in operating lease right of use assets 872 0
Increase in employees and payroll accruals 1,044 184
Decrease in operating lease liabilities (1,208) 0
Increase in accrued expenses and other operating liabilities 945 759
Net cash (used in)/ provided by operating activities (15,901) 4,347
Cash flows from investing activities:    
Acquisition of business, net of cash acquired (99,568) 0
Internal use software capitalization (3,516) 0
Purchase of property and equipment (221) (284)
Founders' note receivable 0 (459)
Decrease in deposits 32 (24)
Net cash used in investing activities (103,273) (767)
Cash flows from financing activities:    
Repayment of acquisition liability 0 (126)
Proceeds from loans 9,000 0
Repayment of loans 0 (3,033)
Payment of SPAC merger transaction costs (3,185) 0
Proceeds from exercise of options 636 367
Net cash (used in)/ provided by financing activities 6,451 (2,792)
Increase/ (decrease) in cash, cash equivalents and restricted cash (112,723) 788
Cash, cash equivalents and restricted cash at the beginning of the period 157,158 16,092
Cash, cash equivalents and restricted cash at the end of the period 44,435 16,880
Supplemental disclosure of cash flows activities:    
Income taxes paid, net of tax refunds 363 80
Interest 137 128
Non-cash transactions    
Business combination consideration paid in stock 47,152 0
Accretion of preferred stock to redemption value 0 44,804
Deferred offering cost included in accrued liabilities 0 1,640
Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position    
Cash and cash equivalents 44,024 16,441
Long-term restricted deposits 411 439
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows $ 44,435 $ 16,880

Source